Related Experiment Video

Updated: Jul 17, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Activated protein C and inflammation in human myocardium after heart surgery

J Petäjä1, E Pesonen, J A Fernández

  • 1Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland. jari.petaja@dlc.fi

American Journal of Hematology
|June 8, 2001
PubMed

Insights

Protein C activation increases during reperfusion following cardiac ischemia. This activation correlates with reduced neutrophil activity, suggesting a role in regulating inflammatory injury during coronary reperfusion.

Area of Science:

  • Cardiovascular Science
  • Hematology
  • Inflammation Research

Background:

  • Ischemic heart disease and reperfusion injury involve complex inflammatory responses.
  • The protein C system is a key regulator of coagulation and inflammation.
  • Understanding interactions between protein C and inflammation during reperfusion is crucial.

Purpose of the Study:

  • To investigate the relationship between inflammation and protein C system activation after ischemia.
  • To assess the impact of protein C activation on neutrophil activity during myocardial reperfusion.

Main Methods:

  • Measured protein C, activated protein C (APC), neutrophil L-selectin, and myeloperoxidase (MPO) activity in 19 patients.
  • Analyzed samples from patients undergoing cardiopulmonary bypass before and after reperfusion.

Main Results:

  • The ratio of activated protein C to protein C (APC/PC) significantly increased post-reperfusion (p=0.015).
  • A negative correlation was found between APC/PC and MPO activity (r=-0.64, p=0.007).
  • APC/PC also negatively correlated with neutrophil L-selectin expression (r=-0.7, p=0.007), indicating reduced neutrophil sequestration.

Conclusions:

  • Post-ischemic protein C activation is associated with decreased neutrophil tissue sequestration.
  • Physiological protein C activation may play a regulatory role in inflammatory injury during human coronary reperfusion.

More Related Videos

A Modified Simple Method for Induction of Myocardial Infarction in Mice04:29

A Modified Simple Method for Induction of Myocardial Infarction in Mice

Published on: December 3, 2021

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy07:40

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...